Research output per year
Research output per year
Research output
Search results
-
2023
Correction: Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment (Oncogene, (2021), 40, 44, (6248-6257), 10.1038/s41388-021-02020-z)
Moskovich, D., Finkelshtein, Y., Alfandari, A., Rosemarin, A., Lifschytz, T., Weisz, A., Mondal, S., Ungati, H., Katzav, A., Kidron, D., Mugesh, G., Ellis, M., Lerer, B. & Ashur-Fabian, O., 2 May 2023, In: Oncogene. 42, 18, p. 1508 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Corrigendum to “DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer” [Canc. Lett. 501 224–233] (Cancer Letters (2021) 501 (224–233), (S0304383520306030), (10.1016/j.canlet.2020.11.011))
Moskovich, D., Alfandari, A., Finkelshtein, Y., Weisz, A., Katzav, A., Kidron, D., Edelstein, E., Veroslavski, D., Perets, R., Arbib, N., Kadan, Y., Fishman, A., Lerer, B., Ellis, M. & Ashur-Fabian, O., 1 Jun 2023, In: Cancer Letters. 563, 216196.Research output: Contribution to journal › Comment/debate
Open Access